Showing results (21-30 of 91) with videos related to

Sort By:
Pageof 10
Molecules (Basel, Switzerland)|August 7, 2021
Selective Inhibitors of the Inducible Nitric Oxide Synthase as Modulators of Cell Responses in LPS-Stimulated Human MonocytesMarialucia Gallorini, Monica Rapino, Helmut Schweikl, et al.
International Journal of Molecular Sciences|December 11, 2022
The Inhibition of the Inducible Nitric Oxide Synthase Enhances the DPSC Mineralization under LPS-Induced InflammationAmelia Cataldi, Rosa Amoroso, Viviana di Giacomo, et al.
Chemmedchem|March 8, 2017
Anticancer Activity of Stilbene-Based DerivativesBarbara De Filippis, Alessandra Ammazzalorso, Marialuigia Fantacuzzi, et al.
Pharmaceuticals (Basel, Switzerland)|June 24, 2022
HDAC Inhibitors for the Therapy of Triple Negative Breast CancerCristina Maccallini, Alessandra Ammazzalorso, Barbara De Filippis, et al.
Anti-Cancer Agents in Medicinal Chemistry|April 3, 2026
Sulfonamides as Aromatase Inhibitors: Nimesulide Analogues, N-cyclic- and Aryl-SulfonamidesCristina Maccallini, Alessandra Ammazzalorso, Barbara De Filippis, et al.
European Journal of Medicinal Chemistry|August 31, 2010
Effect of milrinone analogues on intracellular calcium increase in single living H9C2 cardiac cellsTiziana Pietrangelo, Letizia Giampietro, Barbara De Filippis, et al.
Molecules (Basel, Switzerland)|June 11, 2020
Acetamidine-Based iNOS Inhibitors as Molecular Tools to Counteract Inflammation in BV2 Microglial CellsSilvia Grottelli, Rosa Amoroso, Lara Macchioni, et al.
Neurochemistry International|April 5, 2019
PPAR-γ agonist GL516 reduces oxidative stress and apoptosis occurrence in a rat astrocyte cell lineLetizia Giampietro, Marialucia Gallorini, Barbara De Filippis, et al.
International Journal of Molecular Sciences|January 21, 2023
Phenylsulfonimide PPARα Antagonists Enhance Nrf2 Activation and Promote Oxidative Stress-Induced Apoptosis/Pyroptosis in MCF7 Breast Cancer CellsMarialucia Gallorini, Valentina Di Valerio, Isabella Bruno, et al.
Chemmedchem|December 26, 2017
The Anticancer Potential of Peroxisome Proliferator-Activated Receptor AntagonistsLaura De Lellis, Annamaria Cimini, Serena Veschi, et al.
Pageof 10